Halozyme Therapeutics Inc. Common Stock vs New Era Energy & Digital Inc. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $111.12 (market cap $12.58B), while New Era Energy & Digital Inc. Common Stock trades at $4.7 (market cap $583.45M). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 21.6× New Era Energy & Digital Inc. Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, New Era Energy & Digital Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and New Era Energy & Digital Inc. Common Stock for 0 Days on average.
| HALO | NUAI | |
|---|---|---|
Market Cap | $12.58B | $583.45M |
Volume | 2,179,278 | 17,217,412 |
Sector | Health | Technology |
52-Week High | $115.22 | $8.06 |
52-Week Low | $61.63 | $2.35 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $14.49B | $528.80M |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →New Era Energy & Digital develops large-scale data centers in energy-rich U.S. markets for AI training and inference workloads. Its Texas Critical Data Centers project in the Permian Basin combines modular deployment with flexible power solutions.
Read more on NUAI →